secwatch.observer — SEC 8-K summary
======================================

Issuer:     PURE BIOSCIENCE, INC. (PURE)
CIK:        0001006028
Form:       8-K
Filed at:   2024-08-09T23:59:59+00:00
Accession:  0001493152-24-030966
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pure Bioscience increases authorized common shares from 150M to 200M
--------------------------------------------------------------------

- Shareholders approved the amendment at the Feb 21, 2024 annual meeting.
- Certificate of Amendment filed with Delaware on Aug 5, 2024, effective immediately.
- Authorized common stock increased by 50 million shares (33% increase).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1006028/000149315224030966/0001493152-24-030966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1006028/000149315224030966/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-030966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer